Noveome Biotherapeuticsincis A Clinical Stage Biopharmaceutical Company Based In Pittsburghpennsylvaniafounded In 2000The Company Specializes In Developing Biologic Therapeutics Aimed At Restoring Cellular Integrity In Inflamed Or Damaged Tissuesfocusing On Areas Such As Ophthalmologyneurologydermatologyand Systemic Inflammatory Conditions Noveome S Key Product Is St266A Non Cellular Biologic Derived From Amnion Derived Epithelial Cellsthis Innovative Product Contains Numerous Proteins And Bioactive Factors That Support Neuroprotectioninflammation Modulationand Tissue Healingthe Company Is Actively Conducting Clinical Trials For Various Conditionsincluding Persistent Corneal Epithelial Defects And Systemic Inflammation Related To Covid 19Noveome Holds A Robust Intellectual Property Portfolio With Numerous Patents Covering St266 S Composition And Therapeutic Applicationspositioning Itself As A Leader In Regenerative Medicine
No conferences found for this company.
| Company Name | Noveome Biotherapeutics |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
